Bladder Cancer Flashcards
What is bladder cancer?
Bladder cancer is the most common urinary tract tumour and a common cancer type in the UK, with a higher incidence in males.
What is the most common type of bladder cancer?
Urothelial (transitional cell) carcinoma, accounting for approximately 90% of cases.
What are common risk factors for bladder cancer?
Increasing age, smoking, male sex, occupational chemical exposure, pelvic radiation, cyclophosphamide use, chronic bladder inflammation, and schistosomiasis.
What is the most common presenting symptom of bladder cancer?
Painless visible haematuria, occurring in 80-90% of cases.
What are other possible symptoms of bladder cancer?
Non-visible haematuria, difficulty passing urine, changes in urinary frequency or urgency, recurrent urinary tract infections, pelvic pain, back pain, weight loss, and fatigue.
At what age should patients with unexplained visible haematuria be referred for suspected bladder cancer?
Patients aged 45 and over with unexplained visible haematuria without urinary tract infection, or those with persistent or recurrent visible haematuria after successful treatment of a urinary tract infection.
What are the primary methods for diagnosing bladder cancer?
Urinalysis, urine cytology, flexible cystoscopy, and imaging studies such as CT or MRI.
What is the role of cystoscopy in bladder cancer diagnosis?
Flexible cystoscopy allows direct visualisation of the bladder mucosa to identify tumours and is essential for diagnosis.
What is the purpose of transurethral resection of bladder tumour (TURBT)?
TURBT removes bladder tumours for both diagnostic (histological assessment) and therapeutic purposes.
What are the treatment options for non-muscle-invasive bladder cancer?
Intravesical therapies such as Bacillus Calmette-Guérin (BCG) immunotherapy or intravesical chemotherapy, along with regular surveillance cystoscopies.
What is the standard treatment for muscle-invasive bladder cancer?
Radical cystectomy with urinary diversion, often preceded by neoadjuvant chemotherapy.
What are potential complications of bladder cancer?
Ongoing urinary symptoms, loin pain, hydronephrosis, intractable haematuria, pelvic pain, and metastasis.
What is the 5-year survival rate for superficial bladder tumours?
Approximately 80-90%, though there is a high recurrence rate.
What is the 5-year survival rate for muscle-invasive bladder cancer?
Approximately 30-60%.
What is the 5-year survival rate for metastatic bladder cancer?
Approximately 10-15%.